These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 28906025)

  • 1. Vitamin D in the Parkinson Associated Risk Syndrome (PARS) study.
    Fullard ME; Xie SX; Marek K; Stern M; Jennings D; Siderowf A; Willis AW; Chen-Plotkin AS
    Mov Disord; 2017 Nov; 32(11):1636-1640. PubMed ID: 28906025
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vitamin D and Sunlight Exposure in Newly-Diagnosed Parkinson's Disease.
    Wang J; Yang D; Yu Y; Shao G; Wang Q
    Nutrients; 2016 Mar; 8(3):142. PubMed ID: 26959053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Associations between Vitamin D Status, Supplementation, Outdoor Work and Risk of Parkinson's Disease: A Meta-Analysis Assessment.
    Shen L; Ji HF
    Nutrients; 2015 Jun; 7(6):4817-27. PubMed ID: 26083115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDG PET, dopamine transporter SPECT, and olfaction: Combining biomarkers in REM sleep behavior disorder.
    Meles SK; Vadasz D; Renken RJ; Sittig-Wiegand E; Mayer G; Depboylu C; Reetz K; Overeem S; Pijpers A; Reesink FE; van Laar T; Heinen L; Teune LK; Höffken H; Luster M; Kesper K; Adriaanse SM; Booij J; Leenders KL; Oertel WH
    Mov Disord; 2017 Oct; 32(10):1482-1486. PubMed ID: 28734065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma apolipoprotein A1 as a biomarker for Parkinson disease.
    Qiang JK; Wong YC; Siderowf A; Hurtig HI; Xie SX; Lee VM; Trojanowski JQ; Yearout D; B Leverenz J; Montine TJ; Stern M; Mendick S; Jennings D; Zabetian C; Marek K; Chen-Plotkin AS
    Ann Neurol; 2013 Jul; 74(1):119-27. PubMed ID: 23447138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and Imaging Progression in the PARS Cohort: Long-Term Follow-up.
    Siderowf A; Jennings D; Stern M; Seibyl J; Eberly S; Oakes D; Marek K;
    Mov Disord; 2020 Sep; 35(9):1550-1557. PubMed ID: 32657461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of hypovitaminosis D status in patients with early Parkinson disease.
    Evatt ML; DeLong MR; Kumari M; Auinger P; McDermott MP; Tangpricha V;
    Arch Neurol; 2011 Mar; 68(3):314-9. PubMed ID: 21403017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of vitamin D and Parkinson's disease.
    Peterson AL
    Maturitas; 2014 May; 78(1):40-4. PubMed ID: 24685289
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vitamin D deficiency and its relationship with endothelial dysfunction in patients with early Parkinson's disease.
    Yoon JH; Park DK; Yong SW; Hong JM
    J Neural Transm (Vienna); 2015 Dec; 122(12):1685-91. PubMed ID: 26343034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum 25-hydroxyvitamin D concentrations in Mid-adulthood and Parkinson's disease risk.
    Shrestha S; Lutsey PL; Alonso A; Huang X; Mosley TH; Chen H
    Mov Disord; 2016 Jul; 31(7):972-8. PubMed ID: 27090608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vitamin D levels in Alzheimer's and Parkinson's diseases: a meta-analysis.
    Zhao Y; Sun Y; Ji HF; Shen L
    Nutrition; 2013 Jun; 29(6):828-32. PubMed ID: 23415143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serotonin and dopamine transporter PET changes in the premotor phase of LRRK2 parkinsonism: cross-sectional studies.
    Wile DJ; Agarwal PA; Schulzer M; Mak E; Dinelle K; Shahinfard E; Vafai N; Hasegawa K; Zhang J; McKenzie J; Neilson N; Strongosky A; Uitti RJ; Guttman M; Zabetian CP; Ding YS; Adam M; Aasly J; Wszolek ZK; Farrer M; Sossi V; Stoessl AJ
    Lancet Neurol; 2017 May; 16(5):351-359. PubMed ID: 28336296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Olfactory testing combined with dopamine transporter imaging as a method to detect prodromal Parkinson's disease.
    Ponsen MM; Stoffers D; Wolters ECh; Booij J; Berendse HW
    J Neurol Neurosurg Psychiatry; 2010 Apr; 81(4):396-9. PubMed ID: 19965851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 25-hydroxyvitamin D, vitamin D receptor gene polymorphisms, and severity of Parkinson's disease.
    Suzuki M; Yoshioka M; Hashimoto M; Murakami M; Kawasaki K; Noya M; Takahashi D; Urashima M
    Mov Disord; 2012 Feb; 27(2):264-71. PubMed ID: 22213340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vitamin d deficiency-induced vertebral fractures may cause stooped posture in Parkinson disease.
    Sato Y; Iwamoto J; Honda Y
    Am J Phys Med Rehabil; 2011 Apr; 90(4):281-6. PubMed ID: 21273899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification of Scans Without Evidence of Dopamine Deficit (SWEDD) According to the Olfactory Function.
    Oh YS; Choi JH; Kwon DY
    J Parkinsons Dis; 2016 Oct; 6(4):771-778. PubMed ID: 27567887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vitamin D and Parkinson's disease--a hypothesis.
    Newmark HL; Newmark J
    Mov Disord; 2007 Mar; 22(4):461-8. PubMed ID: 17230473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum vitamin D deficiency and its association with systemic disease in exfoliation syndrome.
    Kocabeyoglu S; Mocan MC; Irkec M; Pinar A; Bozkurt B; Orhan M
    Eur J Ophthalmol; 2013; 23(4):526-31. PubMed ID: 23564611
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vitamin D Insufficiency/Deficiency in HIV-Infected Inner City Youth.
    Poowuttikul P; Thomas R; Hart B; Secord E
    J Int Assoc Provid AIDS Care; 2014; 13(5):438-42. PubMed ID: 23881908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D and Parkinson's disease.
    Vinh Quôc Luong K; Thi Hoàng Nguyên L
    J Neurosci Res; 2012 Dec; 90(12):2227-36. PubMed ID: 22930493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.